SEA-BCMA is a monoclonal antibody that targets the B-Cell Maturation Antigen (BCMA) and is made with Sugar Engineered Antibody (SEA) technology. Researchers believe this approach may improve immune response to cancer cells.
SparkCures ID | 288 |
---|---|
Developed By | Seattle Genetics |
Generic Name | SEA-BCMA |
Treatment Classifications | |
Treatment Targets |
View all active clinical trials around the US.
SparkCures Verified Accurate, up-to-date information. Learn more
The following is a listing of clinical trials for patients with multiple myeloma who have received three or more prior lines of therapy.
SparkCures Verified Accurate, up-to-date information. Learn more
There are no resources, links or videos to display for this treatment.
SparkCures is working closely with Seattle Genetics to provide the most up-to-date information on this treatment. Use the button above to add this treatment to your list of favorites.
Learn more about how we work with industry partners